ORIGINAL RESEARCH ARTICLES
Cardiovascular Safety of VIAN-c4551, an Antiangiogenic Peptide Derived From Vasoinhibin
Relationships Between H2S and OT/OTR Systems in Preeclampsia
Topical eye administration of the antiangiogenic peptide VIAN-c4551 protects against experimental diabetic macular edema
The antiangiogenic peptide VIAN-c4551 inhibits lung melanoma metastasis in mice by reducing pulmonary vascular permeability
Vasoinhibin is Generated by the Renin-angiotensin System
Mass Spectrometric and Immunologic Detection of Prolactin-Derived Vasoinhibin in Human Serum
Immunometric and Functional Measurement of Endogenous Vasoinhibin in Human Sera
Levosulpiride for the treatment of diabetic macular oedema: a phase 2 randomized clinical trial
Vasoinhibin’s Apoptotic, Inflammatory, and Fibrinolytic Actions Are in a Motif Different From Its Antiangiogenic HGR Motif
Human Placental Tissue Contains a Placental Lactogen Derived Vasoinhibin
A Comparative Phylogenetic Analysis of Prolactin Cleavage Sites for the Generation of Vasoinhibin In Vertebrates
Sulpiride-induced hyperprolactinaemia increases retinal vasoinhibin and protects against diabetic retinopathy in rats
Complement Proteins C5/C5a, Cathepsin D and Prolactin in Chondrocytes: A Possible Crosstalk in the Pathogenesis of Osteoarthritis
Plasmin generates vasoinhibin-like peptides by cleaving prolactin and placental lactogen
Development of Vasoinhibin-specific Monoclonal Antibodies
Thrombin Cleaves Prolactin Into a Potent 5.6-kDa Vasoinhibin: Implication for Tissue Repair
The HGR motif is the antiangiogenic determinant of vasoinhibin: implications for a therapeutic orally active oligopeptide
Levosulpiride Increases the Levels of Prolactin and Antiangiogenic Vasoinhibin in the Vitreous of Patients with Proliferative Diabetic Retinopathy
Matrix Metalloproteases and Cathepsin D in Human Serum do not Cleave Prolactin to Generate Vasoinhibin
Improving Immunotherapy Against B-Cell Malignancies Using gammadelta T-Cell-specific Stimulation and Therapeutic Monoclonal Antibodies
Vasoinhibin comprises a three-helix bundle and its antiangiogenic domain is located within the first 79 residues
Basis and Design of a Randomized Clinical Trial to Evaluate the Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema
Human Prolactin Point Mutations and Their Projected Effect on Vasoinhibin Generation and Vasoinhibin-Related Diseases
Higher prolactin and vasoinhibin serum levels associated with incidence and progression of retinopathy of prematurity
Percutaneous Closure of Left Atrial Appendage affects Mid-Term Release of MR-proANP
High Prolactin Excretion in Patients with Diabetes Mellitus and Impaired Renal Function
Vitamin D deficiency decreases survival of bacterial meningoencephalitis in mice
Prolactin promotes cartilage survival and attenuates inflammation in inflammatory arthritis
Prolactin promotes normal liver growth, survival, and regeneration in rodents: effects on hepatic IL-6, suppressor of cytokine signaling-3, and angiogenesis
Melanocortin receptors in rat liver cells: change of gene expression and intracellular localization during acute-phase response
Investigation of prolactin-related vasoinhibin in sera from patients with diabetic retinopathy
orcid.org/0000-0002-1989-8645